nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—CYP2C19—Sorafenib—liver cancer	0.0831	0.284	CbGbCtD
Doxazosin—ABCB1—Sorafenib—liver cancer	0.0671	0.229	CbGbCtD
Doxazosin—CYP2D6—Sorafenib—liver cancer	0.0632	0.216	CbGbCtD
Doxazosin—ABCB1—Doxorubicin—liver cancer	0.0407	0.139	CbGbCtD
Doxazosin—CYP2D6—Doxorubicin—liver cancer	0.0383	0.131	CbGbCtD
Doxazosin—Prazosin—CYP1A1—liver cancer	0.00176	1	CrCbGaD
Doxazosin—Constipation—Sorafenib—liver cancer	0.00165	0.00279	CcSEcCtD
Doxazosin—Vascular purpura—Epirubicin—liver cancer	0.00162	0.00274	CcSEcCtD
Doxazosin—Hypertonia—Doxorubicin—liver cancer	0.00162	0.00274	CcSEcCtD
Doxazosin—Eczema—Epirubicin—liver cancer	0.00161	0.00273	CcSEcCtD
Doxazosin—Abnormal vision—Doxorubicin—liver cancer	0.00161	0.00273	CcSEcCtD
Doxazosin—Eye pain—Epirubicin—liver cancer	0.00161	0.00272	CcSEcCtD
Doxazosin—Mental disability—Doxorubicin—liver cancer	0.0016	0.00271	CcSEcCtD
Doxazosin—Sepsis—Doxorubicin—liver cancer	0.0016	0.00271	CcSEcCtD
Doxazosin—Gastrointestinal pain—Sorafenib—liver cancer	0.00158	0.00267	CcSEcCtD
Doxazosin—Lymphadenopathy—Doxorubicin—liver cancer	0.00157	0.00266	CcSEcCtD
Doxazosin—Hot flush—Epirubicin—liver cancer	0.00155	0.00262	CcSEcCtD
Doxazosin—Increased appetite—Epirubicin—liver cancer	0.00154	0.00261	CcSEcCtD
Doxazosin—Menopausal symptoms—Epirubicin—liver cancer	0.00154	0.0026	CcSEcCtD
Doxazosin—Urticaria—Sorafenib—liver cancer	0.00153	0.00259	CcSEcCtD
Doxazosin—Abdominal pain—Sorafenib—liver cancer	0.00152	0.00258	CcSEcCtD
Doxazosin—Body temperature increased—Sorafenib—liver cancer	0.00152	0.00258	CcSEcCtD
Doxazosin—Purpura—Epirubicin—liver cancer	0.0015	0.00255	CcSEcCtD
Doxazosin—Vascular purpura—Doxorubicin—liver cancer	0.0015	0.00254	CcSEcCtD
Doxazosin—Eczema—Doxorubicin—liver cancer	0.00149	0.00253	CcSEcCtD
Doxazosin—Eye pain—Doxorubicin—liver cancer	0.00149	0.00252	CcSEcCtD
Doxazosin—Cardiac failure—Epirubicin—liver cancer	0.00149	0.00251	CcSEcCtD
Doxazosin—Cerebrovascular accident—Epirubicin—liver cancer	0.00148	0.0025	CcSEcCtD
Doxazosin—Diplopia—Epirubicin—liver cancer	0.00145	0.00245	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00145	0.00245	CcSEcCtD
Doxazosin—Hot flush—Doxorubicin—liver cancer	0.00143	0.00243	CcSEcCtD
Doxazosin—Increased appetite—Doxorubicin—liver cancer	0.00143	0.00242	CcSEcCtD
Doxazosin—Migraine—Epirubicin—liver cancer	0.00143	0.00242	CcSEcCtD
Doxazosin—Affect lability—Epirubicin—liver cancer	0.00143	0.00242	CcSEcCtD
Doxazosin—Menopausal symptoms—Doxorubicin—liver cancer	0.00142	0.00241	CcSEcCtD
Doxazosin—Hypersensitivity—Sorafenib—liver cancer	0.00142	0.0024	CcSEcCtD
Doxazosin—Face oedema—Epirubicin—liver cancer	0.0014	0.00237	CcSEcCtD
Doxazosin—Purpura—Doxorubicin—liver cancer	0.00139	0.00236	CcSEcCtD
Doxazosin—Asthenia—Sorafenib—liver cancer	0.00138	0.00234	CcSEcCtD
Doxazosin—Cardiac failure—Doxorubicin—liver cancer	0.00137	0.00233	CcSEcCtD
Doxazosin—Mood swings—Epirubicin—liver cancer	0.00137	0.00232	CcSEcCtD
Doxazosin—Cerebrovascular accident—Doxorubicin—liver cancer	0.00137	0.00232	CcSEcCtD
Doxazosin—Pruritus—Sorafenib—liver cancer	0.00136	0.00231	CcSEcCtD
Doxazosin—Ataxia—Epirubicin—liver cancer	0.00136	0.00231	CcSEcCtD
Doxazosin—Dehydration—Epirubicin—liver cancer	0.00135	0.00228	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00134	0.00227	CcSEcCtD
Doxazosin—Diplopia—Doxorubicin—liver cancer	0.00134	0.00227	CcSEcCtD
Doxazosin—Liver function test abnormal—Epirubicin—liver cancer	0.00134	0.00227	CcSEcCtD
Doxazosin—Dry skin—Epirubicin—liver cancer	0.00133	0.00225	CcSEcCtD
Doxazosin—Orthostatic hypotension—Epirubicin—liver cancer	0.00132	0.00224	CcSEcCtD
Doxazosin—Migraine—Doxorubicin—liver cancer	0.00132	0.00223	CcSEcCtD
Doxazosin—Affect lability—Doxorubicin—liver cancer	0.00132	0.00223	CcSEcCtD
Doxazosin—Hypokalaemia—Epirubicin—liver cancer	0.00132	0.00223	CcSEcCtD
Doxazosin—Diarrhoea—Sorafenib—liver cancer	0.00132	0.00223	CcSEcCtD
Doxazosin—Face oedema—Doxorubicin—liver cancer	0.00129	0.00219	CcSEcCtD
Doxazosin—Muscular weakness—Epirubicin—liver cancer	0.00128	0.00216	CcSEcCtD
Doxazosin—Dizziness—Sorafenib—liver cancer	0.00127	0.00216	CcSEcCtD
Doxazosin—Mood swings—Doxorubicin—liver cancer	0.00127	0.00215	CcSEcCtD
Doxazosin—Abdominal distension—Epirubicin—liver cancer	0.00126	0.00214	CcSEcCtD
Doxazosin—Ataxia—Doxorubicin—liver cancer	0.00126	0.00213	CcSEcCtD
Doxazosin—Dehydration—Doxorubicin—liver cancer	0.00125	0.00211	CcSEcCtD
Doxazosin—Liver function test abnormal—Doxorubicin—liver cancer	0.00124	0.0021	CcSEcCtD
Doxazosin—Dry skin—Doxorubicin—liver cancer	0.00123	0.00208	CcSEcCtD
Doxazosin—Vomiting—Sorafenib—liver cancer	0.00123	0.00207	CcSEcCtD
Doxazosin—Orthostatic hypotension—Doxorubicin—liver cancer	0.00122	0.00207	CcSEcCtD
Doxazosin—Hypokalaemia—Doxorubicin—liver cancer	0.00122	0.00207	CcSEcCtD
Doxazosin—Angina pectoris—Epirubicin—liver cancer	0.00122	0.00207	CcSEcCtD
Doxazosin—Rash—Sorafenib—liver cancer	0.00122	0.00206	CcSEcCtD
Doxazosin—Dermatitis—Sorafenib—liver cancer	0.00121	0.00206	CcSEcCtD
Doxazosin—Headache—Sorafenib—liver cancer	0.00121	0.00204	CcSEcCtD
Doxazosin—Bronchitis—Epirubicin—liver cancer	0.0012	0.00204	CcSEcCtD
Doxazosin—Muscular weakness—Doxorubicin—liver cancer	0.00118	0.002	CcSEcCtD
Doxazosin—Dysuria—Epirubicin—liver cancer	0.00117	0.00198	CcSEcCtD
Doxazosin—Neutropenia—Epirubicin—liver cancer	0.00117	0.00198	CcSEcCtD
Doxazosin—Abdominal distension—Doxorubicin—liver cancer	0.00117	0.00198	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Epirubicin—liver cancer	0.00116	0.00197	CcSEcCtD
Doxazosin—Pollakiuria—Epirubicin—liver cancer	0.00116	0.00196	CcSEcCtD
Doxazosin—Nausea—Sorafenib—liver cancer	0.00114	0.00194	CcSEcCtD
Doxazosin—Photosensitivity reaction—Epirubicin—liver cancer	0.00114	0.00194	CcSEcCtD
Doxazosin—Weight increased—Epirubicin—liver cancer	0.00114	0.00193	CcSEcCtD
Doxazosin—Weight decreased—Epirubicin—liver cancer	0.00113	0.00192	CcSEcCtD
Doxazosin—Hyperglycaemia—Epirubicin—liver cancer	0.00113	0.00191	CcSEcCtD
Doxazosin—Angina pectoris—Doxorubicin—liver cancer	0.00113	0.00191	CcSEcCtD
Doxazosin—Pneumonia—Epirubicin—liver cancer	0.00112	0.0019	CcSEcCtD
Doxazosin—Drowsiness—Epirubicin—liver cancer	0.00112	0.00189	CcSEcCtD
Doxazosin—Bronchitis—Doxorubicin—liver cancer	0.00111	0.00189	CcSEcCtD
Doxazosin—Jaundice—Epirubicin—liver cancer	0.00109	0.00184	CcSEcCtD
Doxazosin—Conjunctivitis—Epirubicin—liver cancer	0.00109	0.00184	CcSEcCtD
Doxazosin—Urinary tract infection—Epirubicin—liver cancer	0.00109	0.00184	CcSEcCtD
Doxazosin—Neutropenia—Doxorubicin—liver cancer	0.00108	0.00184	CcSEcCtD
Doxazosin—Dysuria—Doxorubicin—liver cancer	0.00108	0.00184	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00108	0.00182	CcSEcCtD
Doxazosin—Sweating—Epirubicin—liver cancer	0.00107	0.00181	CcSEcCtD
Doxazosin—Pollakiuria—Doxorubicin—liver cancer	0.00107	0.00181	CcSEcCtD
Doxazosin—Haematuria—Epirubicin—liver cancer	0.00106	0.0018	CcSEcCtD
Doxazosin—Photosensitivity reaction—Doxorubicin—liver cancer	0.00106	0.00179	CcSEcCtD
Doxazosin—Weight increased—Doxorubicin—liver cancer	0.00105	0.00179	CcSEcCtD
Doxazosin—Epistaxis—Epirubicin—liver cancer	0.00105	0.00178	CcSEcCtD
Doxazosin—Weight decreased—Doxorubicin—liver cancer	0.00105	0.00178	CcSEcCtD
Doxazosin—Sinusitis—Epirubicin—liver cancer	0.00105	0.00177	CcSEcCtD
Doxazosin—Hyperglycaemia—Doxorubicin—liver cancer	0.00105	0.00177	CcSEcCtD
Doxazosin—Pneumonia—Doxorubicin—liver cancer	0.00104	0.00176	CcSEcCtD
Doxazosin—Drowsiness—Doxorubicin—liver cancer	0.00103	0.00175	CcSEcCtD
Doxazosin—Bradycardia—Epirubicin—liver cancer	0.00102	0.00173	CcSEcCtD
Doxazosin—Jaundice—Doxorubicin—liver cancer	0.00101	0.00171	CcSEcCtD
Doxazosin—Rhinitis—Epirubicin—liver cancer	0.00101	0.0017	CcSEcCtD
Doxazosin—Conjunctivitis—Doxorubicin—liver cancer	0.001	0.0017	CcSEcCtD
Doxazosin—Urinary tract infection—Doxorubicin—liver cancer	0.001	0.0017	CcSEcCtD
Doxazosin—Hepatitis—Epirubicin—liver cancer	0.001	0.0017	CcSEcCtD
Doxazosin—Hypoaesthesia—Epirubicin—liver cancer	0.000998	0.00169	CcSEcCtD
Doxazosin—Pharyngitis—Epirubicin—liver cancer	0.000995	0.00168	CcSEcCtD
Doxazosin—Sweating—Doxorubicin—liver cancer	0.000991	0.00168	CcSEcCtD
Doxazosin—Haematuria—Doxorubicin—liver cancer	0.000985	0.00167	CcSEcCtD
Doxazosin—Epistaxis—Doxorubicin—liver cancer	0.000975	0.00165	CcSEcCtD
Doxazosin—Sinusitis—Doxorubicin—liver cancer	0.000969	0.00164	CcSEcCtD
Doxazosin—Visual impairment—Epirubicin—liver cancer	0.000966	0.00164	CcSEcCtD
Doxazosin—Bradycardia—Doxorubicin—liver cancer	0.000944	0.0016	CcSEcCtD
Doxazosin—Eye disorder—Epirubicin—liver cancer	0.000937	0.00159	CcSEcCtD
Doxazosin—Tinnitus—Epirubicin—liver cancer	0.000935	0.00158	CcSEcCtD
Doxazosin—Flushing—Epirubicin—liver cancer	0.00093	0.00158	CcSEcCtD
Doxazosin—Rhinitis—Doxorubicin—liver cancer	0.00093	0.00157	CcSEcCtD
Doxazosin—Hepatitis—Doxorubicin—liver cancer	0.000928	0.00157	CcSEcCtD
Doxazosin—Hypoaesthesia—Doxorubicin—liver cancer	0.000923	0.00156	CcSEcCtD
Doxazosin—Pharyngitis—Doxorubicin—liver cancer	0.000921	0.00156	CcSEcCtD
Doxazosin—Chills—Epirubicin—liver cancer	0.0009	0.00152	CcSEcCtD
Doxazosin—Arrhythmia—Epirubicin—liver cancer	0.000896	0.00152	CcSEcCtD
Doxazosin—Visual impairment—Doxorubicin—liver cancer	0.000894	0.00151	CcSEcCtD
Doxazosin—Alopecia—Epirubicin—liver cancer	0.000886	0.0015	CcSEcCtD
Doxazosin—Mental disorder—Epirubicin—liver cancer	0.000878	0.00149	CcSEcCtD
Doxazosin—Malnutrition—Epirubicin—liver cancer	0.000873	0.00148	CcSEcCtD
Doxazosin—Eye disorder—Doxorubicin—liver cancer	0.000867	0.00147	CcSEcCtD
Doxazosin—Tinnitus—Doxorubicin—liver cancer	0.000865	0.00146	CcSEcCtD
Doxazosin—Flushing—Doxorubicin—liver cancer	0.000861	0.00146	CcSEcCtD
Doxazosin—Flatulence—Epirubicin—liver cancer	0.00086	0.00146	CcSEcCtD
Doxazosin—Tension—Epirubicin—liver cancer	0.000856	0.00145	CcSEcCtD
Doxazosin—Dysgeusia—Epirubicin—liver cancer	0.000855	0.00145	CcSEcCtD
Doxazosin—Nervousness—Epirubicin—liver cancer	0.000848	0.00144	CcSEcCtD
Doxazosin—Back pain—Epirubicin—liver cancer	0.000844	0.00143	CcSEcCtD
Doxazosin—Muscle spasms—Epirubicin—liver cancer	0.000839	0.00142	CcSEcCtD
Doxazosin—Chills—Doxorubicin—liver cancer	0.000832	0.00141	CcSEcCtD
Doxazosin—Arrhythmia—Doxorubicin—liver cancer	0.000829	0.0014	CcSEcCtD
Doxazosin—Vision blurred—Epirubicin—liver cancer	0.000823	0.00139	CcSEcCtD
Doxazosin—Alopecia—Doxorubicin—liver cancer	0.00082	0.00139	CcSEcCtD
Doxazosin—Mental disorder—Doxorubicin—liver cancer	0.000813	0.00138	CcSEcCtD
Doxazosin—Ill-defined disorder—Epirubicin—liver cancer	0.00081	0.00137	CcSEcCtD
Doxazosin—Malnutrition—Doxorubicin—liver cancer	0.000808	0.00137	CcSEcCtD
Doxazosin—Agitation—Epirubicin—liver cancer	0.000802	0.00136	CcSEcCtD
Doxazosin—Flatulence—Doxorubicin—liver cancer	0.000796	0.00135	CcSEcCtD
Doxazosin—Tension—Doxorubicin—liver cancer	0.000792	0.00134	CcSEcCtD
Doxazosin—Dysgeusia—Doxorubicin—liver cancer	0.000791	0.00134	CcSEcCtD
Doxazosin—Malaise—Epirubicin—liver cancer	0.000787	0.00133	CcSEcCtD
Doxazosin—Nervousness—Doxorubicin—liver cancer	0.000784	0.00133	CcSEcCtD
Doxazosin—Vertigo—Epirubicin—liver cancer	0.000784	0.00133	CcSEcCtD
Doxazosin—Syncope—Epirubicin—liver cancer	0.000783	0.00133	CcSEcCtD
Doxazosin—Leukopenia—Epirubicin—liver cancer	0.000781	0.00132	CcSEcCtD
Doxazosin—Back pain—Doxorubicin—liver cancer	0.000781	0.00132	CcSEcCtD
Doxazosin—Muscle spasms—Doxorubicin—liver cancer	0.000776	0.00131	CcSEcCtD
Doxazosin—Palpitations—Epirubicin—liver cancer	0.000771	0.00131	CcSEcCtD
Doxazosin—Loss of consciousness—Epirubicin—liver cancer	0.000767	0.0013	CcSEcCtD
Doxazosin—Cough—Epirubicin—liver cancer	0.000762	0.00129	CcSEcCtD
Doxazosin—Vision blurred—Doxorubicin—liver cancer	0.000761	0.00129	CcSEcCtD
Doxazosin—Convulsion—Epirubicin—liver cancer	0.000756	0.00128	CcSEcCtD
Doxazosin—Hypertension—Epirubicin—liver cancer	0.000754	0.00128	CcSEcCtD
Doxazosin—Ill-defined disorder—Doxorubicin—liver cancer	0.000749	0.00127	CcSEcCtD
Doxazosin—Arthralgia—Epirubicin—liver cancer	0.000743	0.00126	CcSEcCtD
Doxazosin—Myalgia—Epirubicin—liver cancer	0.000743	0.00126	CcSEcCtD
Doxazosin—Chest pain—Epirubicin—liver cancer	0.000743	0.00126	CcSEcCtD
Doxazosin—Agitation—Doxorubicin—liver cancer	0.000742	0.00126	CcSEcCtD
Doxazosin—Anxiety—Epirubicin—liver cancer	0.00074	0.00125	CcSEcCtD
Doxazosin—Discomfort—Epirubicin—liver cancer	0.000734	0.00124	CcSEcCtD
Doxazosin—Malaise—Doxorubicin—liver cancer	0.000728	0.00123	CcSEcCtD
Doxazosin—Dry mouth—Epirubicin—liver cancer	0.000727	0.00123	CcSEcCtD
Doxazosin—Vertigo—Doxorubicin—liver cancer	0.000726	0.00123	CcSEcCtD
Doxazosin—Syncope—Doxorubicin—liver cancer	0.000724	0.00123	CcSEcCtD
Doxazosin—Leukopenia—Doxorubicin—liver cancer	0.000723	0.00122	CcSEcCtD
Doxazosin—Confusional state—Epirubicin—liver cancer	0.000718	0.00122	CcSEcCtD
Doxazosin—Palpitations—Doxorubicin—liver cancer	0.000714	0.00121	CcSEcCtD
Doxazosin—Oedema—Epirubicin—liver cancer	0.000712	0.00121	CcSEcCtD
Doxazosin—Loss of consciousness—Doxorubicin—liver cancer	0.00071	0.0012	CcSEcCtD
Doxazosin—Infection—Epirubicin—liver cancer	0.000708	0.0012	CcSEcCtD
Doxazosin—Cough—Doxorubicin—liver cancer	0.000705	0.00119	CcSEcCtD
Doxazosin—Shock—Epirubicin—liver cancer	0.000701	0.00119	CcSEcCtD
Doxazosin—Convulsion—Doxorubicin—liver cancer	0.0007	0.00118	CcSEcCtD
Doxazosin—Thrombocytopenia—Epirubicin—liver cancer	0.000697	0.00118	CcSEcCtD
Doxazosin—Hypertension—Doxorubicin—liver cancer	0.000697	0.00118	CcSEcCtD
Doxazosin—Tachycardia—Epirubicin—liver cancer	0.000695	0.00118	CcSEcCtD
Doxazosin—Skin disorder—Epirubicin—liver cancer	0.000692	0.00117	CcSEcCtD
Doxazosin—Hyperhidrosis—Epirubicin—liver cancer	0.000689	0.00117	CcSEcCtD
Doxazosin—Myalgia—Doxorubicin—liver cancer	0.000688	0.00116	CcSEcCtD
Doxazosin—Chest pain—Doxorubicin—liver cancer	0.000688	0.00116	CcSEcCtD
Doxazosin—Arthralgia—Doxorubicin—liver cancer	0.000688	0.00116	CcSEcCtD
Doxazosin—Anxiety—Doxorubicin—liver cancer	0.000685	0.00116	CcSEcCtD
Doxazosin—Discomfort—Doxorubicin—liver cancer	0.000679	0.00115	CcSEcCtD
Doxazosin—Anorexia—Epirubicin—liver cancer	0.000679	0.00115	CcSEcCtD
Doxazosin—Dry mouth—Doxorubicin—liver cancer	0.000672	0.00114	CcSEcCtD
Doxazosin—Hypotension—Epirubicin—liver cancer	0.000666	0.00113	CcSEcCtD
Doxazosin—Confusional state—Doxorubicin—liver cancer	0.000665	0.00113	CcSEcCtD
Doxazosin—Oedema—Doxorubicin—liver cancer	0.000659	0.00112	CcSEcCtD
Doxazosin—Infection—Doxorubicin—liver cancer	0.000655	0.00111	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000649	0.0011	CcSEcCtD
Doxazosin—Shock—Doxorubicin—liver cancer	0.000648	0.0011	CcSEcCtD
Doxazosin—Thrombocytopenia—Doxorubicin—liver cancer	0.000645	0.00109	CcSEcCtD
Doxazosin—Insomnia—Epirubicin—liver cancer	0.000644	0.00109	CcSEcCtD
Doxazosin—Tachycardia—Doxorubicin—liver cancer	0.000643	0.00109	CcSEcCtD
Doxazosin—Skin disorder—Doxorubicin—liver cancer	0.00064	0.00108	CcSEcCtD
Doxazosin—Paraesthesia—Epirubicin—liver cancer	0.00064	0.00108	CcSEcCtD
Doxazosin—Hyperhidrosis—Doxorubicin—liver cancer	0.000637	0.00108	CcSEcCtD
Doxazosin—Dyspnoea—Epirubicin—liver cancer	0.000635	0.00108	CcSEcCtD
Doxazosin—Somnolence—Epirubicin—liver cancer	0.000633	0.00107	CcSEcCtD
Doxazosin—Anorexia—Doxorubicin—liver cancer	0.000628	0.00106	CcSEcCtD
Doxazosin—Dyspepsia—Epirubicin—liver cancer	0.000627	0.00106	CcSEcCtD
Doxazosin—Decreased appetite—Epirubicin—liver cancer	0.000619	0.00105	CcSEcCtD
Doxazosin—Hypotension—Doxorubicin—liver cancer	0.000616	0.00104	CcSEcCtD
Doxazosin—Fatigue—Epirubicin—liver cancer	0.000614	0.00104	CcSEcCtD
Doxazosin—Pain—Epirubicin—liver cancer	0.000609	0.00103	CcSEcCtD
Doxazosin—Constipation—Epirubicin—liver cancer	0.000609	0.00103	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.0006	0.00102	CcSEcCtD
Doxazosin—Insomnia—Doxorubicin—liver cancer	0.000596	0.00101	CcSEcCtD
Doxazosin—Paraesthesia—Doxorubicin—liver cancer	0.000592	0.001	CcSEcCtD
Doxazosin—Dyspnoea—Doxorubicin—liver cancer	0.000588	0.000995	CcSEcCtD
Doxazosin—Feeling abnormal—Epirubicin—liver cancer	0.000587	0.000994	CcSEcCtD
Doxazosin—Somnolence—Doxorubicin—liver cancer	0.000586	0.000992	CcSEcCtD
Doxazosin—Gastrointestinal pain—Epirubicin—liver cancer	0.000582	0.000986	CcSEcCtD
Doxazosin—Dyspepsia—Doxorubicin—liver cancer	0.00058	0.000982	CcSEcCtD
Doxazosin—Decreased appetite—Doxorubicin—liver cancer	0.000573	0.00097	CcSEcCtD
Doxazosin—Fatigue—Doxorubicin—liver cancer	0.000568	0.000962	CcSEcCtD
Doxazosin—Urticaria—Epirubicin—liver cancer	0.000566	0.000958	CcSEcCtD
Doxazosin—Constipation—Doxorubicin—liver cancer	0.000564	0.000954	CcSEcCtD
Doxazosin—Pain—Doxorubicin—liver cancer	0.000564	0.000954	CcSEcCtD
Doxazosin—Abdominal pain—Epirubicin—liver cancer	0.000563	0.000953	CcSEcCtD
Doxazosin—Body temperature increased—Epirubicin—liver cancer	0.000563	0.000953	CcSEcCtD
Doxazosin—Feeling abnormal—Doxorubicin—liver cancer	0.000543	0.00092	CcSEcCtD
Doxazosin—Gastrointestinal pain—Doxorubicin—liver cancer	0.000539	0.000913	CcSEcCtD
Doxazosin—Hypersensitivity—Epirubicin—liver cancer	0.000525	0.000889	CcSEcCtD
Doxazosin—Urticaria—Doxorubicin—liver cancer	0.000524	0.000887	CcSEcCtD
Doxazosin—Abdominal pain—Doxorubicin—liver cancer	0.000521	0.000882	CcSEcCtD
Doxazosin—Body temperature increased—Doxorubicin—liver cancer	0.000521	0.000882	CcSEcCtD
Doxazosin—Asthenia—Epirubicin—liver cancer	0.000511	0.000865	CcSEcCtD
Doxazosin—Pruritus—Epirubicin—liver cancer	0.000504	0.000853	CcSEcCtD
Doxazosin—Diarrhoea—Epirubicin—liver cancer	0.000487	0.000825	CcSEcCtD
Doxazosin—Hypersensitivity—Doxorubicin—liver cancer	0.000486	0.000822	CcSEcCtD
Doxazosin—Asthenia—Doxorubicin—liver cancer	0.000473	0.000801	CcSEcCtD
Doxazosin—Dizziness—Epirubicin—liver cancer	0.000471	0.000798	CcSEcCtD
Doxazosin—Pruritus—Doxorubicin—liver cancer	0.000466	0.00079	CcSEcCtD
Doxazosin—Vomiting—Epirubicin—liver cancer	0.000453	0.000767	CcSEcCtD
Doxazosin—Diarrhoea—Doxorubicin—liver cancer	0.000451	0.000764	CcSEcCtD
Doxazosin—Rash—Epirubicin—liver cancer	0.000449	0.00076	CcSEcCtD
Doxazosin—Dermatitis—Epirubicin—liver cancer	0.000449	0.00076	CcSEcCtD
Doxazosin—Headache—Epirubicin—liver cancer	0.000446	0.000756	CcSEcCtD
Doxazosin—Dizziness—Doxorubicin—liver cancer	0.000436	0.000738	CcSEcCtD
Doxazosin—Nausea—Epirubicin—liver cancer	0.000423	0.000716	CcSEcCtD
Doxazosin—Vomiting—Doxorubicin—liver cancer	0.000419	0.00071	CcSEcCtD
Doxazosin—Rash—Doxorubicin—liver cancer	0.000416	0.000704	CcSEcCtD
Doxazosin—Dermatitis—Doxorubicin—liver cancer	0.000415	0.000703	CcSEcCtD
Doxazosin—Headache—Doxorubicin—liver cancer	0.000413	0.000699	CcSEcCtD
Doxazosin—Nausea—Doxorubicin—liver cancer	0.000391	0.000663	CcSEcCtD
Doxazosin—ADRA1B—GPCR downstream signaling—IL2—liver cancer	3.02e-05	0.000261	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KDR—liver cancer	3.01e-05	0.000261	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK14—liver cancer	2.99e-05	0.000259	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CB—liver cancer	2.98e-05	0.000259	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GOT2—liver cancer	2.97e-05	0.000257	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ESR1—liver cancer	2.93e-05	0.000254	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CB—liver cancer	2.92e-05	0.000253	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF2—liver cancer	2.91e-05	0.000252	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.91e-05	0.000252	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP1A1—liver cancer	2.9e-05	0.000251	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—F2—liver cancer	2.89e-05	0.000251	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PSMD10—liver cancer	2.87e-05	0.000249	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PSMA4—liver cancer	2.87e-05	0.000249	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP2E1—liver cancer	2.86e-05	0.000248	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PRKCE—liver cancer	2.86e-05	0.000248	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—KRAS—liver cancer	2.85e-05	0.000247	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CD—liver cancer	2.82e-05	0.000245	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GOT2—liver cancer	2.79e-05	0.000242	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP2E1—liver cancer	2.79e-05	0.000242	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CG—liver cancer	2.77e-05	0.00024	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APC—liver cancer	2.77e-05	0.00024	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.77e-05	0.00024	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2—liver cancer	2.74e-05	0.000237	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TERT—liver cancer	2.73e-05	0.000237	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CSF2—liver cancer	2.72e-05	0.000236	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—RAF1—liver cancer	2.71e-05	0.000235	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CB—liver cancer	2.71e-05	0.000235	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF2—liver cancer	2.71e-05	0.000235	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—MTHFR—liver cancer	2.7e-05	0.000234	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—H2AFX—liver cancer	2.68e-05	0.000232	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2—liver cancer	2.68e-05	0.000232	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYCS—liver cancer	2.67e-05	0.000232	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARA—liver cancer	2.65e-05	0.00023	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CB—liver cancer	2.65e-05	0.00023	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.63e-05	0.000228	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP2E1—liver cancer	2.63e-05	0.000228	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GOT1—liver cancer	2.62e-05	0.000227	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GGT1—liver cancer	2.62e-05	0.000227	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PIK3CA—liver cancer	2.61e-05	0.000227	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYCS—liver cancer	2.61e-05	0.000226	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—BRAF—liver cancer	2.6e-05	0.000226	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GOT1—liver cancer	2.56e-05	0.000222	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GGT1—liver cancer	2.56e-05	0.000222	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—liver cancer	2.53e-05	0.000219	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CSF2—liver cancer	2.53e-05	0.000219	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—RAF1—liver cancer	2.52e-05	0.000219	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KDR—liver cancer	2.5e-05	0.000216	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—H2AFX—liver cancer	2.49e-05	0.000216	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2—liver cancer	2.49e-05	0.000216	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK14—liver cancer	2.48e-05	0.000215	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CB—liver cancer	2.46e-05	0.000213	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYCS—liver cancer	2.46e-05	0.000213	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CD—liver cancer	2.43e-05	0.000211	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2—liver cancer	2.43e-05	0.000211	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ESR1—liver cancer	2.43e-05	0.000211	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TERT—liver cancer	2.42e-05	0.00021	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—HRAS—liver cancer	2.42e-05	0.00021	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GOT1—liver cancer	2.41e-05	0.000209	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GGT1—liver cancer	2.41e-05	0.000209	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PIK3CA—liver cancer	2.41e-05	0.000209	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SERPINE1—liver cancer	2.41e-05	0.000209	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—F2—liver cancer	2.4e-05	0.000208	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—KRAS—liver cancer	2.38e-05	0.000207	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTP1—liver cancer	2.36e-05	0.000204	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—HMOX1—liver cancer	2.32e-05	0.000201	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTP1—liver cancer	2.3e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CG—liver cancer	2.3e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APC—liver cancer	2.3e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CG—liver cancer	2.27e-05	0.000197	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—HMOX1—liver cancer	2.27e-05	0.000197	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2—liver cancer	2.26e-05	0.000196	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TERT—liver cancer	2.25e-05	0.000195	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KDR—liver cancer	2.22e-05	0.000192	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK14—liver cancer	2.2e-05	0.000191	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PIK3CA—liver cancer	2.19e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—liver cancer	2.19e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RAF1—liver cancer	2.17e-05	0.000188	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTP1—liver cancer	2.17e-05	0.000188	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTM1—liver cancer	2.16e-05	0.000188	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BRAF—liver cancer	2.16e-05	0.000187	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ESR1—liver cancer	2.16e-05	0.000187	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMOX1—liver cancer	2.14e-05	0.000185	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—liver cancer	2.14e-05	0.000185	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—F2—liver cancer	2.13e-05	0.000185	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CB—liver cancer	2.12e-05	0.000184	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MTOR—liver cancer	2.12e-05	0.000184	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—liver cancer	2.11e-05	0.000183	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—liver cancer	2.06e-05	0.000179	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP1A1—liver cancer	2.05e-05	0.000178	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK14—liver cancer	2.05e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APC—liver cancer	2.04e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CG—liver cancer	2.04e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HRAS—liver cancer	2.03e-05	0.000176	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CD—liver cancer	2.02e-05	0.000175	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ESR1—liver cancer	2.01e-05	0.000174	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP1A1—liver cancer	2e-05	0.000174	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CA—liver cancer	2e-05	0.000174	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—liver cancer	2e-05	0.000173	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CD—liver cancer	1.99e-05	0.000173	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1B—liver cancer	1.99e-05	0.000173	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—liver cancer	1.99e-05	0.000173	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—F2—liver cancer	1.98e-05	0.000172	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—KRAS—liver cancer	1.98e-05	0.000172	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—liver cancer	1.97e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—liver cancer	1.97e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP3—liver cancer	1.95e-05	0.000169	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—liver cancer	1.95e-05	0.000169	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—liver cancer	1.94e-05	0.000168	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BRAF—liver cancer	1.92e-05	0.000166	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—liver cancer	1.91e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCND1—liver cancer	1.9e-05	0.000165	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APC—liver cancer	1.9e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CG—liver cancer	1.9e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—JUN—liver cancer	1.9e-05	0.000164	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP1A1—liver cancer	1.89e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CTNNB1—liver cancer	1.88e-05	0.000163	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARA—liver cancer	1.88e-05	0.000163	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—liver cancer	1.87e-05	0.000162	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—liver cancer	1.84e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1A—liver cancer	1.84e-05	0.000159	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARA—liver cancer	1.83e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	1.82e-05	0.000158	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RAF1—liver cancer	1.8e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	1.79e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK8—liver cancer	1.79e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—liver cancer	1.79e-05	0.000155	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BRAF—liver cancer	1.78e-05	0.000155	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	1.78e-05	0.000154	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	1.78e-05	0.000154	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	1.76e-05	0.000153	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MTOR—liver cancer	1.76e-05	0.000153	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—liver cancer	1.76e-05	0.000153	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—KRAS—liver cancer	1.76e-05	0.000152	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CB—liver cancer	1.74e-05	0.000151	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARA—liver cancer	1.73e-05	0.00015	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.69e-05	0.000146	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HRAS—liver cancer	1.68e-05	0.000146	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	1.67e-05	0.000145	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—liver cancer	1.66e-05	0.000144	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	1.65e-05	0.000143	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	1.65e-05	0.000143	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	1.65e-05	0.000143	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—liver cancer	1.64e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	1.64e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—KRAS—liver cancer	1.63e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP3—liver cancer	1.62e-05	0.00014	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—liver cancer	1.62e-05	0.00014	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	1.61e-05	0.00014	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—liver cancer	1.61e-05	0.00014	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CG—liver cancer	1.61e-05	0.000139	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAF1—liver cancer	1.6e-05	0.000139	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCND1—liver cancer	1.58e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JUN—liver cancer	1.57e-05	0.000136	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CG—liver cancer	1.57e-05	0.000136	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	1.56e-05	0.000136	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MTOR—liver cancer	1.56e-05	0.000136	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	1.56e-05	0.000135	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—liver cancer	1.55e-05	0.000134	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—liver cancer	1.53e-05	0.000133	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	1.53e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—liver cancer	1.52e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—liver cancer	1.52e-05	0.000132	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—liver cancer	1.51e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	1.5e-05	0.00013	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HRAS—liver cancer	1.49e-05	0.00013	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK8—liver cancer	1.49e-05	0.000129	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAF1—liver cancer	1.49e-05	0.000129	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—liver cancer	1.48e-05	0.000129	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CG—liver cancer	1.48e-05	0.000128	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	1.47e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	1.45e-05	0.000126	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MTOR—liver cancer	1.45e-05	0.000126	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	1.45e-05	0.000126	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP3—liver cancer	1.44e-05	0.000125	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—liver cancer	1.44e-05	0.000125	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—liver cancer	1.43e-05	0.000124	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—liver cancer	1.43e-05	0.000124	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CD—liver cancer	1.41e-05	0.000123	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KRAS—liver cancer	1.41e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCND1—liver cancer	1.4e-05	0.000121	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JUN—liver cancer	1.4e-05	0.000121	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—liver cancer	1.39e-05	0.000121	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HRAS—liver cancer	1.39e-05	0.00012	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	1.39e-05	0.00012	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CD—liver cancer	1.38e-05	0.00012	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—liver cancer	1.37e-05	0.000119	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	1.36e-05	0.000118	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—liver cancer	1.36e-05	0.000118	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—liver cancer	1.36e-05	0.000118	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—liver cancer	1.36e-05	0.000118	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	1.36e-05	0.000117	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	1.35e-05	0.000117	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP3—liver cancer	1.34e-05	0.000116	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—liver cancer	1.34e-05	0.000116	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—liver cancer	1.33e-05	0.000115	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK8—liver cancer	1.32e-05	0.000115	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—liver cancer	1.32e-05	0.000114	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCND1—liver cancer	1.3e-05	0.000113	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CD—liver cancer	1.3e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JUN—liver cancer	1.3e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	1.29e-05	0.000112	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	1.29e-05	0.000112	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—liver cancer	1.28e-05	0.000111	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—liver cancer	1.26e-05	0.00011	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—liver cancer	1.26e-05	0.00011	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—liver cancer	1.26e-05	0.000109	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	1.26e-05	0.000109	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—liver cancer	1.25e-05	0.000109	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CB—liver cancer	1.23e-05	0.000107	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK8—liver cancer	1.23e-05	0.000107	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—liver cancer	1.23e-05	0.000106	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—liver cancer	1.22e-05	0.000106	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—liver cancer	1.21e-05	0.000105	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CB—liver cancer	1.2e-05	0.000104	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HRAS—liver cancer	1.2e-05	0.000104	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KRAS—liver cancer	1.17e-05	0.000101	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—liver cancer	1.15e-05	9.93e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—liver cancer	1.13e-05	9.84e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CB—liver cancer	1.13e-05	9.82e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—liver cancer	1.12e-05	9.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—liver cancer	1.12e-05	9.74e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—liver cancer	1.12e-05	9.72e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	1.07e-05	9.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CA—liver cancer	1.06e-05	9.19e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—liver cancer	1.06e-05	9.16e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—liver cancer	1.04e-05	9.05e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—liver cancer	1.04e-05	9.03e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—liver cancer	1.04e-05	9.01e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KRAS—liver cancer	1.04e-05	9e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HRAS—liver cancer	9.93e-06	8.61e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KRAS—liver cancer	9.65e-06	8.36e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	9.54e-06	8.27e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—liver cancer	9.51e-06	8.24e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—liver cancer	9.23e-06	8e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	8.86e-06	7.68e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HRAS—liver cancer	8.82e-06	7.65e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—liver cancer	8.77e-06	7.6e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—liver cancer	8.66e-06	7.51e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—liver cancer	8.57e-06	7.43e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—liver cancer	8.45e-06	7.32e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HRAS—liver cancer	8.2e-06	7.11e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—liver cancer	7.85e-06	6.8e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—liver cancer	7.79e-06	6.75e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CA—liver cancer	7.51e-06	6.51e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CA—liver cancer	7.33e-06	6.35e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—liver cancer	7.24e-06	6.28e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CA—liver cancer	6.91e-06	5.99e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—liver cancer	6.13e-06	5.32e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—liver cancer	5.99e-06	5.19e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—liver cancer	5.64e-06	4.89e-05	CbGpPWpGaD
